INmune Bio Inc. (INMB)
Allarity Therapeutics Inc. (ALLR)
Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment
INVO Bioscience Inc (INVO)
Oculis Holding AG (OCS)
Oculis birtir boð á aðalfund
Athira Pharma Inc (ATHA)
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
Oculis Holding AG (OCS)
Oculis Publishes Invitation to the Annual General Meeting
Entera Bio Ltd. (ENTX)
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
Dermata Therapeutics Inc. (DRMA)
ReShape Lifesciences Inc. (RSLS)
New Form 8-K - ReShape Lifesciences Inc. Filed: 2025-05-09 AccNo: 0001104659-25-046717 Size: 271 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Mustang Bio Inc (MBIO)
Spok Holdings Inc (SPOK)
TransMedics Group Inc. (TMDX)
Stevanato Group SpA (STVN)
Stevanato Group to Participate in Upcoming Investor Conferences